Podcast thumbnail for Freely Filtered, a NephJC Podcast

Freely Filtered, a NephJC Podcast

Claim This Podcast

by NephJC Team

4.8(75 reviews)
97 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
57

Podcast Authority

Beta
FairBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality76
Social0
YouTube0
Engagement95

Podcast Overview

<p>Twice monthly (aspirational) recap of the NephJC journal club. NephJC reviews the most important manuscripts which are driving nephrology forward and improving our understanding of the kidney.</p>

Language

🇺🇲

Publishing Since

3/25/2019

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

57

Podcast Authority

Beta
FairBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality76
Social0
YouTube0
Engagement95
7
Excellent Areas
3
Good Performance
9
Growth Opportunities
excellent
Episode Length
50 minutes
Performing excellently!
good
Show Notes Quality
3.0/5

Recommendations available

Unlock the full report to see detailed tips

needs improvement
Publishing Consistency
Every 27 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for Freely Filtered, a NephJC Podcast

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for FF93 Hyponatremia Interventional Trial

June 30, 2026

FF93 Hyponatremia Interventional Trial

Host Joel Topf interviews Professor Ewout J. Hoorn and Assistant Physician Harish Seethapathy about the Hyponatremia Interventional Trial, revealing insights into targeted hyponatremia correction.

Episode thumbnail for FF92 Live from Dublin, The Irish Nephrology Society

June 9, 2026

FF92 Live from Dublin, The Irish Nephrology Society

Dr. Joel Topf interviews Dr. Samir Parikh and Prof. Donal Reddan about Irish nephrology and their society's work.

Episode thumbnail for FF91 Liberate-D

March 30, 2026

FF91 Liberate-D

<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">The Filtrate</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Joel Topf</strong> <a href="https://bsky.app/profile/kidneyboy.bsky.social">kidneyboy.bsky.social</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Pedro Teixeira</strong> <a href="https://bsky.app/profile/nephcrit.bsky.social">@nephcrit.bsky.social</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Nayan Arora </strong><a href="https://bsky.app/profile/captainchloride.bsky.social">@captainchloride.bsky.social</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Anna Gaddy </strong><a target="_blank" href="https://bsky.app/profile/annagaddy.bsky.social">@annagaddy.bsky.social</a> </p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Swapnil Hiremath </strong><a href="https://bsky.app/profile/hswapnil.medsky.social">@hswapnil.medsky.social</a> and on <a target="_blank" href="https://www.linkedin.com/in/swapnilhiremath/">LinkedIn</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"></p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;">Special Guests</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Ian McCoy, MD</strong> <a href="https://x.com/NephroNinja">@NephroNinja</a> study author and <a href="https://www.ucsfhealth.org/providers/ian-mccoy">UCSF</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Chi-yuan</strong> <strong>Hsu</strong> Senior author and <a href="https://profiles.ucsf.edu/chi-yuan.hsu">Chief of the Division of Nephrology at UCSF</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Samuel Silver</strong> <a href="https://deptmed.queensu.ca/people/samuel-silver">Associate Professor</a> at Queens University in Canada</p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;">Editing</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>Vipin Verghese</strong> and<strong> Joel Topf</strong></p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;"></p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;">Show Notes </p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">NephJC Discusion: <a href="https://www.nephjc.com/news/liberated-aki">Dialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Manuscript: <strong>A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury</strong>The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial <a href="https://jamanetwork.com/journals/jama/fullarticle/2841171">JAMA</a> | <a href="https://pubmed.ncbi.nlm.nih.gov/41201895/">PubMed</a></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Ben’s pilot study: RAD-AKI Pilot study: <strong>Recovery After Dialysis-Requiring Acute Kidney Injury (RAD-AKI) </strong>(<a href="https://clinicaltrials.gov/study/NCT03305549">ClinicalTrials.gov</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">STARRT-AKI <a href="https://www.nephjc.com/news/starrt-aki">NephJC</a> </p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Editorial in JAMA: <strong>A-E-I-O-U and Sometimes Why—Dialysis in Acute Kidney Injury </strong>(<a href="https://jamanetwork.com/journals/jama/fullarticle/2841172">JAMA</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>What Is Dialytrauma?</strong> (<a href="https://www.docwirenews.com/post/what-is-dialytrauma">Nephrology Times</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>How Fragile Are the Results of a Trial?</strong> The Fragility Index (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7485073/">PubMedCentral</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Shiffl Trial: <strong>Daily Hemodialysis and the Outcome of Acute Renal Failure</strong> (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa010877">NEJM</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">AKIKI: <strong>Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit</strong> (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1603017">NEJM</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">AKIKI2: <strong>How Late it was, How Late!</strong> (<a href="https://www.nephjc.com/news/akiki-2">NephJC</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Sam Silver’s study: <strong>Promoting Kidney Recovery After Acute Kidney Injury Receiving Dialysis (Recover-AKI) </strong>(<a href="https://clinicaltrials.gov/study/NCT04948476">ClinicalTrial.Gov</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Marie Kondo (<a href="https://en.wikipedia.org/wiki/Marie_Kondo">Wikipedia</a>)</p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;">Tubular Secretions</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Swap: The smutty dragon novels of novels of Rebecca Yarros (<a href="https://en.wikipedia.org/wiki/Rebecca_Yarros">Wikipedia</a>) Specifically <strong>The Empyrean series</strong></p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Anna: Brisket recipes</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Pedro: <strong>The Naked Gun</strong> (<a href="https://en.wikipedia.org/wiki/The_Naked_Gun_(2025_film)">Wikipedia</a>) with Liam Neeson</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Ian: <strong>ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury</strong> (<a href="https://pubmed.ncbi.nlm.nih.gov/40014384/">PubMed</a>) he really doesn’t get Tubular Secretions.</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Nayan: <strong>Tilt: A Novel</strong> by Emma Pattee (<a href="https://www.amazon.com/Tilt-Novel-Emma-Pattee/dp/1668055481/ref=sr_1_1?adgrpid=185786214865&amp;dib=eyJ2IjoiMSJ9.vsouq55-48aeD20KyEaGRh-V4mVrG2E-zppeL44EmLEAexCxA5T8C0NbEiTJtsFepey3KqkHncNAX2msW9UVrFg5wi3437SyRE7Lp2ij_mON-6rPV7fgJuqCtAnIz2dJK6ZlvlT41MnTLESZM22fszTYak-EjtTBVzFDHXGZdY04wftQ0OQmmI17w0qyNwRCn-istzOQOTwbme5LGHDAt7-V3lBCZ5rsjIME7F5DFWU.0RE0glXxUdl97m0ACr36NPnUvcBs8-CHvGtufBOmxc4&amp;dib_tag=se&amp;hvadid=779541324606&amp;hvdev=c&amp;hvexpln=0&amp;hvlocphy=9016826&amp;hvnetw=g&amp;hvocijid=3426977299259243241--&amp;hvqmt=e&amp;hvrand=3426977299259243241&amp;hvtargid=kwd-2552187199392&amp;hydadcr=23203_13755239_2458124&amp;keywords=tilt%20emma%20pattee&amp;mcid=b5dd7b672b163e819fc2b95b8ed12f4b&amp;qid=1774913320&amp;sr=8-1">Amazon</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Chi: <strong>The Year of Magical Thinking</strong> by Joan Didion (<a href="https://en.wikipedia.org/wiki/The_Year_of_Magical_Thinking">Wikipedia</a>) and <strong>Innovations in Nephrology</strong> (<a href="https://link.springer.com/book/10.1007/978-3-031-11570-7">Springer Nature</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Sam: <strong>Monopoly Super Electronic Banking Board Game</strong> (<a href="https://www.amazon.com/Hasbro-Games-Monopoly-Electronic-Banking/dp/B083YKFYN3">Amazon</a>)</p><p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">Joel: <strong>Song Sung Blue </strong>(<a href="https://en.wikipedia.org/wiki/Song_Sung_Blue_(2025_film)">Wikipedia</a>)</p>

97 total episodes available with 16 transcripts

Recent guests on Freely Filtered, a NephJC Podcast

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Ewout J Hoorn

Guest

Harish Seethapathy

Guest

Samir Parikh

Guest

Donal Reddan

Guest

Catherine Godson

Guest

Charles Edelstein

Guest

Michelle Rheault

Guest

Deep-dive analytics for Freely Filtered, a NephJC Podcast

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Freely Filtered, a NephJC Podcast?
<p>Twice monthly (aspirational) recap of the NephJC journal club. NephJC reviews the most important manuscripts which are driving nephrology forward and improving our understanding of the kidney.</p>
How often does this podcast release new episodes?

This podcast updates bi-weekly.

Where can I listen to this podcast?

This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.